Summary of Financial Results 2025
  • 2025/05/14
サブ-ナビゲーション
  • 【リダイレクト】
  • HOME
  • 現在位置:News Release
  • Company
    • Basic Philosophy
    • Top Message
    • Corporate Governance
    • Business Activities
    • Company Outline
      • Board of Directors and Executive Officers
      • History
    • Office Locations
    • Affiliate Companies
  • Sustainability
    • About Sustainability
    • Sustainability Policy
      • The Environment
      • Community Involvement and Development
      • Consumer Issues
      • Fair Operating Practices
      • Human Rights & Labor Practices
      • Organizational Governance
    • Sustainability Initiatives
      • Resolving Social Issues
      • Environmental Improvement Initiatives
      • Realizing Better Workplaces & Human Resource Development
      • Living With & Contributing to Local Communities
  • Business Activities
    • Products
      • Gelatin
      • Collagen Peptide
        • Wellnex® DI-PEPTIDE
        • Wellnex® standard type
      • Food Material
      • Biomedical
    • Market/Application
      • Health Support
      • Biomedical
        • Cellmatrix
          • How to choose Cellmatrix Type I products
        • beMatrix
        • LET Gelatin
        • MedGel II
        • Other Products Line-up
        • Basic Knowledge
        • About Us
          • Wellcome
        • Brochure, Reference & Manual
          • Brochure & Reference
          • Safety Data Sheet
        • FAQ
  • Investor Relations
    • Corporate Governance
    • Financial Information
      • Financial Highlight (Full Year)
      • Financial Indicator (Consolidated)
    • IR Library
      • Earnings Reports
      • Annual Reports
      • Presentation
    • Disclosure Policy
    • IR Contact
  • Access
  • Web Institute
    • Biomedical Lab.
      • 01. Living with the Cells
      • 02. Expansion to medical field
      • 03. Medical applications related to collagen and gelatin
    • Peptide Lab.
      • 01. Basic Knowledge
      • 02. Absorption
      • 03. Skin
        • 03. Skin (Clinical Trial)
        • 03. Skin (Mechanism 1)
        • 03. Skin (Mechanism 2)
      • 04. Pressure Ulcer
        • 04. Pressure Ulcer (Clinical Trial)
        • 04. Pressure Ulcer (Mechanism)
      • 05. Blood Vessel
      • 06. Bone
      • 07. Blood Sugar
      • 08. Muscle
      • 09. Joint
        • 09. Joint (Clinical Trial)
        • 09. Joint (Animal Studies)
        • 09. Joint (Mechanism)
      • 10. Video Library
  • Basic Information Security Policy
  • Privacy Policy
  • Cookie Policy
  • Basic Social Media Policy
    • Social Media Terms of Service
  • Contact Us
    • Corporate Contact
    • Biomedical Contact
  • Contact Us

Summary of Financial Results 2025

  • 2025/05/14

News Release

Company

Basic Philosophy

Top Message

Corporate Governance

Business Activities

Company Outline

Office Locations

Affiliate Companies

Sustainability

About Sustainability

Sustainability Policy

Sustainability Initiatives

Business Activities

Products

Market / Application

Investor Relations

Corporate Governance

Financial Information

IR Library

Disclosure Policy

IR Contact

  • 日本語
  • English
  • 中文
  • Access

ページの先頭へ

News Release

Company

Basic Philosophy

Top Message

Corporate Governance

Business Activities

Company Outline

  • Board of Directors and Executive Officers
  • History

Office Locations

Affiliate Companies

Sustainability

About Sustainability

Sustainability Policy

Sustainability Initiatives

Business Activities

Products

Market / Application

Investor Relations

Corporate Governance

Financial Information

  • Financial Highlight (Full Year)
  • Financial Indicator (Consolidated)

IR Library

  • Earnings Reports
  • Annual Reports
  • Presentation

Disclosure Policy

IR Contact

  • Contact Us
  • Basic Information Security Policy
  • Privacy Policy
  • Cookie Policy
  • Basic Social Media Policy
  • Access

© Nitta Gelatin Inc. All rights reserved